TVA Medical Inc. announced that its everlinQ 4 endoAVF System has received CE Mark in the European Union. The technology uses a 4 French catheter system with enhanced visual indicators to create hemodialysis access using an endovascular technique without open surgery.

October 4, 2017 — MyoKardia Inc. recently provided a clinical update on its MYK-491 program for dilated cardiomyopathy.

Earlier this year, MyoKardia initiated a Phase 1 single ascending dose trial of MYK-491 in healthy volunteers. The objectives of this randomized, placebo-controlled trial are to assess safety, tolerability, preliminary pharmacokinetics and pharmacodynamics of MYK-491.

October 4, 2017 — Medtronic received U.S. Food and Drug Administration (FDA) approval for its HeartWare HVAD System as a destination therapy for patients with advanced heart failure who are not candidates for heart transplants. The HVAD System, a left ventricular assist device (LVAD), helps the heart pump and increases the amount of blood that flows through the body.

For U.S. Cardiologists. Age and Income Continue to Rise
For U.S. Cardiologists, Age and Income Continue to Rise

Despite expectations to the contrary, a new survey from cardiovascular healthcare consulting firm MedAxiom finds that overall, cardiology compensation continues to increase. The company’s fifth annual Cardiovascular Provider Compensation and Production Survey also revealed that one in five cardiologists is over the age of 61, and that overall compensation for private cardiologists is increasing faster than that of their integrated counterparts; the differential in compensation is at its lowest point in five years.

October 3, 2017 – Medical Metrics, an experienced core laboratory for multi-center clinical trials, has implemented the Digisonics Cardiovascular Information System (CVIS) for cardiology research. Digisonics provides cardiologists with remote functionality via Virtual Desktop Infrastructure (VDI), Digisonics’ latest platform validated for secured access to cardiology images.

October 2, 2017 — Cardiovascular healthcare membership organization and performance community MedAxiom announced its corporate partnership with pMD to help advance value-based cardiovascular healthcare. pMD is a healthcare technology provider that improves the physician experience and patient care through a platform focused on mobile charge capture and HIPAA-compliant information sharing.

October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Wingman14C Crossing Catheter for use in conjunction with a guidewire to access discrete regions of the coronary vasculature.

Medtronic plc recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro valve in everyday clinical practice. Studying patients with severe symptomatic aortic stenosis at an intermediate, high or extreme risk for open-heart surgery, the FORWARD PRO Clinical Study will evaluate longer-term performance (out to five years) of the next-generation self-expanding transcatheter aortic valve implantation (TAVI) system, which was recently approved for commercial use in Europe and United States.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now